Charles Tilden Everson, MD in Marrero, LA - Thoracic Surgery (Cardiothoracic Vascular Surgery)

Charles Tilden Everson, MD is a Thoracic Surgery (cardiothoracic Vascular Surgery) physician based in Marrero, Louisiana. Charles Tilden Everson is licensed to practice in Louisiana (license number 06267R) and his current practice location is 1111 Medical Center Blvd, Ste. N703, Marrero, Louisiana. He can be reached at his office (for appointments etc.) via phone at (504) 349-4901.

NPI number for Charles Tilden Everson is 1518913367 and his current mailing address is 1111 Medical Center Blvd, Ste. N703, Marrero, Louisiana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1518913367.

Contact Information

	Charles Tilden Everson, MD
	1111 Medical Center Blvd, Ste. N703, Marrero, LA 70072-3151
	(504) 349-4901
	(504) 349-6755

Physician's Profile

Full Name	Charles Tilden Everson
Gender	Male
Speciality	Thoracic Surgery (cardiothoracic Vascular Surgery)
Location	1111 Medical Center Blvd, Marrero, Louisiana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1518913367
Provider Enumeration Date: 05/25/2006
Last Update Date: 07/29/2013

Medical Identifiers

Medical identifiers for Charles Tilden Everson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1518913367	NPI	-	NPPES
1355062	Medicaid	LA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208600000X	Surgery	06267R (Louisiana)	Secondary
208600000X	Surgery	MD06267R (Louisiana)	Secondary
208G00000X	Thoracic Surgery (cardiothoracic Vascular Surgery)	06267R (Louisiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Charles Tilden Everson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Charles Tilden Everson, MD 1111 Medical Center Blvd, Ste. N703, Marrero, LA 70072-3151 Ph: (504) 349-4901	Charles Tilden Everson, MD 1111 Medical Center Blvd, Ste. N703, Marrero, LA 70072-3151 Ph: (504) 349-4901

News Archive

Antidepressant warnings linked to decreased prescription rates among children

Regulatory warnings regarding the risk of suicidal thoughts and behaviors appear to be associated with reductions in the number of antidepressant medication prescriptions among children and adolescents covered by Tennessee's expanded Medicaid program, according to a report in the July issue of Archives of Pediatrics & Adolescent Medicine.

Univfy, Stanford scientists develop first validated prognostic test for predicting IVF live birth outcomes

Univfy, a pioneer in the development of personalized in vitro fertilization (IVF) prognostic tools, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by its founding scientific team and clinical collaborators from Stanford University.

GOP candidates for California governor struggle with budget issues, including health care

The two candidates in California's Republican gubernatorial primary, Steve Poizner and Meg Whitman, "agree on several budget fixes, including a spending cap, a hiring freeze, and reforms to welfare, pensions and prison health care." Both candidates seek to rid waste and create a leaner, more cost efficient budget, but cuts can come at a cost. "Reaction to Schwarzenegger's proposed budget revision this month indicates what the next governor is in for.

Study looks at fighting 'epidemic' of dangerous behavior

While drivers tend to believe it is dangerous to text and drive, many say they can still do it safely. Now Washington State University researchers say drivers can be discouraged from the practice with public service announcements that evoke their fear of death in graphic terms.

FDA approves Biologics' IMBRUVICA as oral agent for treatment of patients with CLL

Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

Charles Tilden Everson, MD - Thoracic Surgery (Cardiothoracic Vascular Surgery) in Marrero, LA